USA TODAY Network / ReutersAs the GLP-1 weight-loss drug market continues to grow, consumers weary of needles now have two options in pill form instead. Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo…

Editor's Picks

Latest News